Clinical Trials Browser

NCT03816345 2026-03-18

Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer

Arthritis, Rheumatoid, Autoimmune Diseases, Colitis, Ulcerative, Crohn Disease, Dermatomyositis, Lupus Erythematosus, Systemic, Multiple Sclerosis, Psoriasis, Scleroderma, Systemic, Sjogren's Syndrome, Inflammatory Bowel Diseases, Arthritis, Psoriatic, Hematologic Neoplasms

NCT02450396 2026-03-16

EGR2

Withdrawn

Myeloid

Arthritis, Rheumatoid, Lupus Erythematosus, Systemic, Mastocytosis, Myositis, Sjogren's Syndrome, Vasculitis, Arthritis, Psoriatic, Antiphospholipid Syndrome, Spondylarthritis, Rare Diseases, Scleroderma, Diffuse

NCT07470151 2026-03-13

Clinical Study of EVM18001 in the Treatment of Refractory Autoimmune Diseases

Phase NA Recruiting

12 enrolled

Autoimmune Diseases, Lupus Erythematosus, Systemic, Myasthenia Gravis, Scleroderma, Diffuse

NCT07000110 2026-02-20

SIMA

Recruiting

3,195 enrolled

Infections, Lupus Erythematosus, Systemic, Neoplasms

NCT07249060 2025-12-03

INTER-AUTENTIC

Recruiting

300 enrolled

Lupus Erythematosus, Systemic, Myositis, Scleroderma, Systemic, Sjogren's Syndrome

NCT04751396 2025-11-10

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

Recruiting

125 enrolled

Dermatologic

Arthritis, Rheumatoid, Autoimmune Diseases, Colitis, Ulcerative, Crohn Disease, Lupus Erythematosus, Systemic, Melanoma, Psoriasis, Spondylitis, Ankylosing, Inflammatory Bowel Diseases, Arthritis, Psoriatic, Arthritis, Reactive

NCT05478018 2025-09-09

LUPEX

Phase NA Completed

55 enrolled

Lupus Erythematosus, Systemic

NCT03938324 2025-07-28

PiCASO

Phase NA Completed

222 enrolled 11 charts

Classical hematology

Anemia, Sickle Cell, Cystic Fibrosis, Diabetes Mellitus, Type 1, Lupus Erythematosus, Systemic, Neoplasms, Inflammatory Bowel Diseases, Renal Insufficiency, Chronic

NCT04870333 2025-06-20

PROTECT-V

Phase 2/3 Completed

2,240 enrolled

COVID-19, Glomerulonephritis, Lupus Erythematosus, Systemic, Neoplasms, Vasculitis

NCT06429800 2025-04-24

A Study to Evaluate the Safety and Preliminary Efficacy of ATA3219 in Participants With Systemic Lupus Erythematosus

Phase 1 Withdrawn

Lupus Erythematosus, Systemic, Lupus Nephritis, Epstein-Barr Virus Infections